Skip to main content

Find Clinical Trials

Home
Conditions
Anemia, Hypoplastic, Congenital

Clinical trial condition

Anemia, Hypoplastic, Congenital

Explore clinical trials studying Anemia, Hypoplastic, Congenital. Study availability and eligibility vary by location and protocol.

101 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Hypoplastic, Congenital trial results

Completed

Human Placental-Derived Stem Cell Transplantation

NCT01586455

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
Locations: Children's Hospital Colorado Denver, Colorado, United States

New York Medical College Valhalla, New York, United States

University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

NCT02873975

Conditions: Advanced Cancers, Anemia, Anemia, Aplastic, +12 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

NCT00900055

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +29 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

NCT00258427

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +11 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

TBI Dose De-escalation for Fanconi Anemia

NCT00352976

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +11 more
Locations: University of Minnesota Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

NCT00630253

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +11 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

NCT03609814

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +27 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation

NCT01316549

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +26 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

NCT03609827

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +27 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

NCT00919503

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +51 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Oregon Health and Science University Portland, Oregon, United States

Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details